Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against Bordetella pertussis intracerebral challenge

Microbes and Infection

Volumn 10, Issue 2, 2008, Pages 198-202

  Nascimento, Ivan P ^a   Dias, Waldely O ^a   Quintilio, Wagner ^a   Christ, Ana P ^a   Moraes, Josefina F ^a   Vancetto, Mary D C ^a   Ribeiro dos Santos, Gabriela ^a   Raw, Isaias ^a   Leite, Luciana C C ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

Neonates; Pertussis; Recombinant BCG vaccine

Indexed keywords

BCG VACCINE; CD4 ANTIGEN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; GAMMA INTERFERON; PERTUSSIS TOXIN; PERTUSSIS VACCINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BORDETELLA PERTUSSIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; EXPERIMENTAL MOUSE; HUMORAL IMMUNITY; IMMUNIZATION; MOUSE; NEWBORN; NEWBORN CARE; NEWBORN INFECTION; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; WHOLE CELL;

ANIMALS; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CD4-POSITIVE T-LYMPHOCYTES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HUMANS; INFANT, NEWBORN; INTERFERON TYPE II; MICE; MYCOBACTERIUM BOVIS; PERTUSSIS TOXIN; PERTUSSIS VACCINE; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA; WHOOPING COUGH;

BORDETELLA PERTUSSIS; MUS;

EID: 39749110723     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.10.010     Document Type: Article

References (15)

1. Mattoo S., and Cherry J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18 (2005) 326-382
2. E.S. Bamberger, I. Srugo, What is new in pertussis? Eur. J. Pediatr, in press, doi:10.1007/s00431-007-0548-2.
3. Miller E. Overview of recent clinical trials of acellular pertussis vaccines. Biologicals 27 (1999) 79-86
4. Scuffham P.A., and McIntyre P.B. Pertussis vaccination strategies for neonates - an exploratory cost-effectiveness analysis. Vaccine 22 (2004) 2953-2964
5. Adkins B. T-cell function in newborn mice and humans. Immunol. Today 20 (1999) 330-335
6. Siegrist C.A. Neonatal and early life vaccinology. Vaccine 19 (2001) 3331-3346
7. Ohara N., and Yamada T. Recombinant BCG vaccines. Vaccine 19 (2001) 4089-4098
8. Ota M.O., Vekemans J., Schlegel-Haueter S.E., Fielding K., Sanneh M., Kidd M., Newport M.J., Aaby P., Whittle H., Lambert P.H., McAdam K.P., Siegrist C.A., and Marchant A. Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination. J. Immunol. 15 (2002) 919-925
9. Mills K. Immunity to Bordetella pertussis. Microbes Infect 3 (2001) 655-677
10. Pizza M., Covacci A., Bartoloni A., Perugini M., Nencioni L., De Magistris M.T., Villa L., Nucci D., Manetti R., Bugnoli M., Giovannoni F., Olivieri R., Barbieri J.T., Sato H., and Rappuoli R. Mutants of pertussis toxin suitable for vaccine development. Science 246 (1989) 497-500
11. Nascimento I.P., Dias W.O., Mazzantini R.P., Miyaji E.N., Gamberini M., Quintilio W., Gebara V.C., Cardoso D.F., Ho P.L., Raw I., Winter N., Gicquel B., Rappuoli R., and Leite L.C.C. Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice. Infect. Immun. 68 (2000) 4877-4883
12. Roduilt C., Bozzotti P., Mielcarek N., Lambert P.H., del Giudice G., Locht C., and Siegrist C. Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis. Infect. Immun. 70 (2002) 3521-3528
13. Kendrick P.L., Eldering G., Dixon M.K., and Misner J. Mouse protection tests in the study of pertussis vaccine - a comparative series using intracerebral route for challenge. Am. J. Public Health 37 (1947) 803-810
14. Mascart F., Verscheure V., Malfroot A., Hainaut M., Pierard D., Temerman S., Peltier A., Debrie A.S., Levy J., del Giudice G., and Locht C. Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses. J. Immunol. 170 (2003) 1504-1509
15. Daniel N.W., Mann P.B., and Buboltz A.M. E.T. Harvill delayed role of tumor necrosis factor-α in overcoming the effects of pertussis toxin. J. Infect. Dis. (2007) electronically published